Literature DB >> 21040915

Children with familial hypercholesterolemia are characterized by an inflammatory imbalance between the tumor necrosis factor α system and interleukin-10.

Ingunn Narverud1, Thor Ueland, Marit S Nenseter, Kjetil Retterstøl, Vibeke H Telle-Hansen, Bente Halvorsen, Leiv Ose, Pål Aukrust, Kirsten B Holven.   

Abstract

OBJECTIVE: Familial hypercholesterolemia (FH) is associated with increased risk of premature atherosclerosis. Increasing evidence supports involvement of inflammation in atherogenesis. The inflammatory cytokine tumor necrosis factor (TNF)α has been regarded as a key mediator in the development of atherosclerosis due to its involvement in several stages in this process. We hypothesized that children with FH, as a model of early atherosclerosis, have different serum levels of inflammation markers than healthy control children.
METHODS: We measured serum levels of TNFα, as well as its endogenous inhibitors (i.e., soluble TNF receptors [sTNFR] 1 and 2) and the anti-inflammatory cytokine interleukin (IL)-10 in healthy children (7-20 years) with (n=102) and without (n=48) heterozygote FH as well as adult FH subjects (n=20) and healthy adult controls (n=16).
RESULTS: The main findings were: Compared to control children, FH children had higher serum levels of TNFα, accompanied by lower sTNFRs levels, resulting in an increased TNFα/sTNFRs ratio (P<0.05), potentially reflecting enhanced TNFα activity. In contrast to the increased TNFα levels, FH children had decreased serum levels of IL-10 (P<0.01) resulting in an increased TNFα/IL-10 ratio (P<0.01). We did not observe any difference in the same parameters between adult subjects with and without FH.
CONCLUSIONS: FH children are characterized by an inflammatory imbalance between TNFα and IL-10, potentially contributing to the accelerated atherosclerotic process in these individuals. Copyright Â
© 2010 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21040915     DOI: 10.1016/j.atherosclerosis.2010.10.002

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN: 0021-9150            Impact factor:   5.162


  7 in total

1.  Early onset of coronary heart disease in a young woman with familial hypercholesterolemia: coronary findings and effect of short term treatment with high dose atorvastatin.

Authors:  Natale Daniele Brunetti; Deodata Montrone; Riccardo Ieva; Antonio Ruggiero; Michele Correale; Luisa De Gennaro; Matteo Di Biase
Journal:  J Thromb Thrombolysis       Date:  2012-02       Impact factor: 2.300

2.  Soluble tumor necrosis factor receptors are associated with severity of kidney dysfunction in pediatric chronic kidney disease.

Authors:  Janaina Matos Moreira; Albená Nunes da Silva; Érica Leandro Marciano Vieira; Antônio Lúcio Teixeira; Arthur Melo Kummer; Ana Cristina Simões E Silva
Journal:  Pediatr Nephrol       Date:  2018-10-29       Impact factor: 3.714

3.  Western Diet Triggers NLRP3-Dependent Innate Immune Reprogramming.

Authors:  Anette Christ; Patrick Günther; Mario A R Lauterbach; Peter Duewell; Debjani Biswas; Karin Pelka; Claus J Scholz; Marije Oosting; Kristian Haendler; Kevin Baßler; Kathrin Klee; Jonas Schulte-Schrepping; Thomas Ulas; Simone J C F M Moorlag; Vinod Kumar; Min Hi Park; Leo A B Joosten; Laszlo A Groh; Niels P Riksen; Terje Espevik; Andreas Schlitzer; Yang Li; Michael L Fitzgerald; Mihai G Netea; Joachim L Schultze; Eicke Latz
Journal:  Cell       Date:  2018-01-11       Impact factor: 41.582

4.  IL-35 is a novel responsive anti-inflammatory cytokine--a new system of categorizing anti-inflammatory cytokines.

Authors:  Xinyuan Li; Jietang Mai; Anthony Virtue; Ying Yin; Ren Gong; Xiaojin Sha; Stefanie Gutchigian; Andrew Frisch; Imani Hodge; Xiaohua Jiang; Hong Wang; Xiao-Feng Yang
Journal:  PLoS One       Date:  2012-03-16       Impact factor: 3.240

5.  Dyslipidemia rather than Type 2 Diabetes Mellitus or Chronic Periodontitis Affects the Systemic Expression of Pro- and Anti-Inflammatory Genes.

Authors:  Rafael Nepomuceno; Bárbara Scoralick Villela; Sâmia Cruz Tfaile Corbi; Alliny De Souza Bastos; Raquel Alves Dos Santos; Catarina Satie Takahashi; Silvana Regina Perez Orrico; Raquel Mantuaneli Scarel-Caminaga
Journal:  Mediators Inflamm       Date:  2017-02-20       Impact factor: 4.711

Review 6.  Systemic consequences of abnormal cholesterol handling: Interdependent pathways of inflammation and dyslipidemia.

Authors:  Ross O'Hagan; Alex R Berg; Christin G Hong; Philip M Parel; Nehal N Mehta; Heather L Teague
Journal:  Front Immunol       Date:  2022-08-26       Impact factor: 8.786

7.  HELP LDL apheresis reduces plasma pentraxin 3 in familial hypercholesterolemia.

Authors:  Michela Zanetti; Mariagrazia Zenti; Rocco Barazzoni; Federica Zardi; Annamaria Semolic; Michele Giuseppe Messa; Filippo Mearelli; Gianpaolo Russi; Maurizio Fonda; Luca Scarano; Enzo Bonora; Luigi Cattin
Journal:  PLoS One       Date:  2014-07-11       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.